Frost & Sullivan Cancer Therapies Analyst Briefing


Published on

Frost & Sullivan’s analyst briefing on the cancer therapies.

Frost & Sullivan Cancer Therapies Analyst Briefing

  1. 1. Cancer Therapies: Getting Targeted and More Personalized Sangeetha Prabakar, Industry Analyst Technical Insights, Healthcare 9th September 2008
  2. 2. Scope of the Analyst Briefing An overview of cancer therapies Emerging trends in cancer therapies Overview of the factors influencing the future of cancer therapies Key opportunities for cancer research Drivers, restraints and challenges affecting cancer therapies Technology road map Noteworthy technologies and products 2
  3. 3. Areas of Major Advances Nanotechnology 3
  4. 4. Diagnostics Companion Diagnostics Prognosis Real Time Screening Drug Toxicity Drug Response Monitoring Prediction of Recurrence Pharmacogenomic Studies Microarrays 4
  5. 5. Therapeutics Targeted Therapy Monoclonal Antibodies Enzyme Inhibitors Proteasome Inhibitors Angiogenesis Inhibitors 5
  6. 6. Drug Delivery Targeted Delivery Liposomes Nanoparticles Nanodrug Implants Polymer Drug Conjugates 6
  7. 7. Future Paradigm of Cancer Care Personalized Personalized One drug for a One drug for a care – Patient care – one pill specific single phenotype specific drug for individual population cocktails patient. Medium Low High Molecular Diagnostics Microarrays Targeted Therapies Nanotechnology Drug Delivery Technologies 7
  8. 8. Future Economic Trends in Cancer Care Molecular Profiling Molecular Phenotype Tumor Genotype Tumor Subtype Disease Stage Personalized Medicine 8
  9. 9. Growth Drivers for Cancer Drugs 9
  10. 10. Growth Restraining Factors for Anticancer Drugs Complicated Nature of Chemotherapy Side Effects of Chemotherapy Inadequate Data on Cancer Subtypes Multiple Drug Resistance Inherent Features of Cancer Cells Complicate Drug Targeting Poor Target Specificity/Poor Drug Solubility Insurance/High Costs/Tough Regulatory Environment Expiring Patent/Generic Threat Need for Regionalization of Clinical Trials Growth Restraining Factors for Anticancer Drugs 10
  11. 11. Emerging Cancer Research Opportunities 11
  12. 12. Key Players and Their Innovations 12
  13. 13. Your Feedback is Important to Us What would you like to see from Frost & Sullivan? Growth Forecasts? Competitive Structure? Emerging Trends? Strategic Recommendations? Other? Please inform us by taking our survey. 13
  14. 14. For Additional Information • To leave a comment, ask the analyst a question, or receive the free audio segment that accompanies this presentation, please contact Stephanie Ochoa, Social Media Manager at (210) 247- 2421, via email,, or on Twitter at 14